Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Ardent Health securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3]. - To serve as lead plaintiff, individuals must file a motion with the Court by March 9, 2026 [3]. Group 2: Case Background - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming an active monitoring process that was not actually employed [5]. - Defendants reportedly downplayed increased claim denials by third-party payors and did not write off uncollectible accounts, which inflated reported accounts receivable [5]. - The firm did not maintain sufficient professional malpractice liability insurance, contrary to its representations, leading to potential investor damages when the truth was revealed [5].

We came across a bullish thesis on Cardinal Health, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on CAH. Cardinal Health, Inc.'s share was trading at $226.18 as of February 25th. CAH’s trailing and forward P/E were 24.57 and 16.92, respectively according to Yahoo Finance. ImmunityBio (IBRX) Extends Rally on 8th Day on Strong Clinical Trial Results Jirsak/Shutterstock.com Cardinal Health, Inc. operates as a healthcare services and products company in the United States ...

Core Insights - The article discusses IQVIA Holdings Inc.'s recent performance, highlighting a revenue of $4.017 billion in Q2, which was driven by growth in the Technology & Analytics Solutions (TAS) segment [1]. Company Performance - IQVIA reported a revenue of $4.017 billion in Q2, indicating a strong performance compared to previous quarters [1]. - The growth in revenue is primarily attributed to the Technology & Analytics Solutions (TAS) segment, suggesting a focus on innovative solutions within the healthcare sector [1]. Investment Focus - The article emphasizes the importance of innovative companies in the biotech and pharmaceutical sectors, particularly those developing breakthrough therapies with potential acquisition catalysts [1].

SAN FRANCISCO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is notifying investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top executives. CLICK HERE TO SUBMIT YOUR ARDT LOSSES The litigation focuses on the revelation in Nov. 2025 that Ardent alleged utilized a rigid 180-day cliff to reserve for uncollectible accounts – a process that the complaint alle ...

Core Insights - The partnership between Kahuna Workforce Solutions and Skillcentrix aims to enhance skills data for frontline healthcare roles, starting with nursing, within Workday [1][3] - The collaboration addresses the challenge of ensuring validated, role-specific skills data in healthcare, which is crucial for staffing, compliance, and patient safety [2][6] Company Overview - Kahuna Workforce Solutions is a SaaS platform focused on skills and competency management, providing validated skills data to improve workforce capabilities and training investments [9] - Skillcentrix specializes in Workday solutions, helping organizations define and operationalize talent strategies, particularly in healthcare [11] Partnership Objectives - The partnership seeks to define clear, role-specific capability and competency requirements for regulated frontline roles [10] - It aims to continuously validate frontline skills through operational workflows, ensuring readiness is auditable and current [10] - The collaboration enhances Workday Skills Cloud by providing a trusted skills signal for staffing and workforce planning [6][10] Industry Impact - While primarily focused on healthcare, the solution also applies to other regulated industries such as energy, manufacturing, and transportation, where validated capabilities are essential [7][8]

BrightSpring Health Services (NasdaqGS:BTSG) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAJ Rice - Managing DirectorCharles Rhyee - Managing DirectorDavid Deuchler - Investor RelationsJared Haase - Equity Research AssociateJen Phipps - CFOJon Rousseau - President and CEOMatthew Gillmor - DirectorWhit Mayo - Senior Managing DirectorConference Call ParticipantsAnn Hynes - Senior Healthcare Services Equity Analyst and Managing DirectorBrian Tanquilut - Senior AnalystDavid Larsen - A ...

ARDT SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ardent Health (ARDT) Investors of Securities Class Action Deadline on April 21, 2026 [Accessibility Statement] Skip NavigationFaruqi & Faruqi, LLP Securities Litigation Partner [James (Josh) Wilson] Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in [Ardent] between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruq ...

The U.S. Core PPI will also be closely monitored today. Economists expect January figures to be +0.3% m/m and +3.0% y/y, compared to +0.7% m/m and +3.3% y/y in December.Today, all eyes are focused on the U.S. Producer Price Index, which is set to be released in a couple of hours. The PPI will provide further insight into the outlook for inflation. Economists, on average, forecast that the U.S. January PPI will stand at +0.3% m/m and +2.6% y/y, compared to the previous figures of +0.5% m/m and +3.0% y/y.Mean ...

Group 1 - The healthcare arm of Malaysian conglomerate Sunway is planning to raise approximately $736.3 million [1] - This IPO would mark Malaysia's largest initial public offering in nearly a decade [1]

Humana Inc. (NYSE:HUM) is included among the 14 Best GARP Stocks to Buy According to Analysts. Barclays Lowers Humana (HUM) Price Target amid Questions on Margin Expansion Outlook On February 25, Barclays lowered its price recommendation on Humana Inc. (NYSE:HUM) to $176 from $245. The firm reiterated an Equal Weight rating on the shares. It said it is “incrementally cautious” about the company’s expectation that Individual Medicare Advantage margins will double. A February 14 Bloomberg report said Huma ...